Skip to content
2000
Volume 3, Issue 3
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

The last 10 years have seen resurgent industry activity in discovery and development of new drugs for the treatment of tuberculosis (TB), a growing widespread and devastating (more than 2 million deaths annually) bacterial infection that is of increasing concern in developing and developed nations alike. This review describes drugs currently being evaluated in the clinic for treatment of uncomplicated and drug resistant pulmonary TB, and updates the literature on 5 new drugs that entered clinical trials in the last 4 years.

Loading

Article metrics loading...

/content/journals/mc/10.2174/157340607780620626
2007-05-01
2025-10-31
Loading full text...

Full text loading...

/content/journals/mc/10.2174/157340607780620626
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test